Watch the latest episode of focusIR Fireside Chats: Why Edinburgh Investment Trust Is Backing Turnaround Stocks for 2026 Growth. Viewhere

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksDialight Regulatory News (DIA)

Share Price Information for Dialight (DIA)

Share Price is delayed by 15 minutes
Get Live Data
426.00    1.00 (0.24%)
Bid:
410.00
Ask:
420.00
Spread: 10.00 (2.439%)
Market Cap: £170.29m
DIA Live PriceLast checked at - London Stock Exchange

Intraday Dialight Share Chart

Director/PDMR Shareholding

27 Mar 2017 10:26

RNS Number : 6076A
Dialight PLC
27 March 2017
 

Dialight plc ("Company")

 

Director/PDMR Shareholdings

27 March 2017

 

Options and Awards under the Dialight plc 2014 Performance Share Plan ("PSP")

 

On 24 March 2017 the under-mentioned Director/Person Discharging Managerial Responsibility, was granted a nil cost option which entitled her to receive ordinary shares of 1.89 pence each in the Company in accordance with the rules of the PSP.

 

Name

Number of Options granted under the PSP

Total number of shares over which incentive awards in the PSP held following notification

% of issued class

Fariyal Khanbabi (Director)

26,588

108,153

0.333

 

On 24 March 2017 the under-mentioned Director/Persons Discharging Managerial Responsibility, were granted a conditional award, which entitled them to acquire ordinary shares of 1.89 pence each in the Company in accordance with the rules of the PSP.

 

Name

Number of shares awarded under the PSP

Total number of shares over which incentive awards in the PSP held following notification

% of issued class

Michael Sutsko

(Director)

58,930

227,059

0.698

Rizwan Ahmad

4,092

15,201

0.047

Dennis Geary

3,973

10,673

0.033

John Peck

4,092

15,201

0.047

Michael Schratz

4,469

15,974

0.049

Matt Boudiette

2,979

8,004

0.025

 

Options and awards will normally vest on the third anniversary of grant subject to continued employment. In relation to the awards made to Michael Sutsko and Fariyal Khanbabi only, the award and option (respectively) are subject to the satisfaction of two performance conditions as set out below.

25% of the option or award is measured against the Company's total shareholder return ("TSR") over the three year period relative to the FTSE SmallCap Index (excluding investment trusts) ("TSR Performance Condition"), and 75% of the option or award is measured against the Company's underlying earnings per share ("EPS") in 2019 ("EPS Performance Condition").

TSR Performance Condition

No part of an option or award subject to the TSR Performance Condition shall vest if the percentage increase in the Company's TSR is below the percentage increase in the TSR of the comparator index. 25% of the ordinary shares subject to the TSR Performance Condition will vest if the percentage increase in the Company's TSR is equal to the percentage increase in the TSR of the comparator index, rising on a straight-line basis to 100% vesting if the percentage increase in the Company's TSR is equal to the increase in the TSR of the index plus 10% per annum.

EPS Performance Condition

No part of an option or award subject to the EPS Performance Condition will vest if the Company's 2019 EPS is below 62p, 25% of the ordinary shares subject to the EPS Option/Award will vest if the Company's 2019 EPS exceeds 62p, rising on a straight-line basis to 100% vesting if the Company's 2019 EPS exceeds 78p.

No consideration was paid for the grant of these options and awards and no consideration is due to be paid by the participant on the vesting of these options and awards. On vesting, options will be exercisable between 24 March 2020 and 24 March 2022.

 

Holding Period

A mandatory two-year post-vesting holding period applies to the PSP options/awards granted to Fariyal Khanbabi and Michael Sutsko.

 

 

This announcement is made in accordance with Article 19.3 of the Market Abuse Regulation.

 

Chris Fussell

General Counsel and Company Secretary

Tel: +44 (0) 20 3058 3546

 

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
DSHPGUWPWUPMUBM
Date   Source Headline
14th Mar 20252:42 pmRNSHolding(s) in Company
4th Feb 20257:30 amRNSDirector Declaration
4th Feb 20257:00 amRNSHolding(s) in Company
28th Jan 20257:00 amRNSTrading Statement
10th Dec 20247:00 amRNSDirectorate Change
25th Nov 20247:00 amRNSHalf-year Report
11th Nov 20247:00 amRNSDirectorate Change
4th Nov 20242:03 pmRNSDate of half-year results
25th Sep 20245:03 pmRNSDirector/PDMR Shareholding
25th Sep 20247:00 amRNSSanmina Litigation
24th Sep 20247:00 amRNSSanmina Litigation
23rd Sep 202412:31 pmRNSResult of AGM
16th Sep 20247:00 amRNSDirector/PDMR Shareholding
30th Aug 20247:00 amRNSDirector/PDMR Shareholding
19th Aug 202410:13 amRNSNotice of AGM
16th Aug 20246:10 pmRNSNotice of AGM
12th Aug 20247:00 amRNSDirector/PDMR Shareholding
1st Aug 20247:00 amRNSDirectorate Change
31st Jul 20243:27 pmRNSAnnual Financial Report
30th Jul 20247:00 amRNSFinal Results
29th Jul 20245:34 pmRNSChange of Registered Office
29th Jul 20247:00 amRNSNon-core disposal
23rd Jul 20247:30 amRNSSanmina Litigation
13th Jun 20247:00 amRNSUpdate Announcement
7th May 20247:00 amRNSTotal Voting Rights
19th Apr 20247:00 amRNSDirector/PDMR Shareholding
28th Mar 202411:00 amRNSAdmission of New Shares
12th Mar 20245:55 pmRNSHolding(s) in Company
12th Mar 20244:56 pmRNSHolding(s) in Company
26th Feb 20242:39 pmRNSDirector/PDMR Shareholding
19th Feb 20249:16 amRNSDirectorate Change
19th Feb 20247:00 amRNSStatement re second interim results
16th Feb 20247:00 amRNSDirectorate Change
30th Jan 20247:00 amRNSCFO Appointment
30th Jan 20247:00 amRNSTrading Update
2nd Jan 20247:00 amRNSSanmina Litigation
29th Nov 20231:04 pmRNSSanmina Litigation
7th Nov 20235:40 pmRNSHolding(s) in Company
7th Nov 20235:24 pmRNSHolding(s) in Company
7th Nov 20233:52 pmRNSHolding(s) in Company
1st Nov 202312:03 pmRNSPDMR Shareholding
1st Nov 202311:50 amRNSTotal Voting Rights and Capital
1st Nov 202311:15 amRNSBlock listing Interim Review
31st Oct 20234:32 pmRNSHolding(s) in Company
27th Oct 202312:05 pmRNSResults of General Meeting
4th Oct 202311:52 amRNSCirc re. Related Party Transaction
27th Sep 20237:00 amRNSResult of Equity Issue
26th Sep 20235:07 pmRNSREX Retail Offer
26th Sep 20235:05 pmRNSProposed Placing and Retail Offer
18th Sep 202312:25 pmRNSStatement re Update on Financing

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.